Materials and methods
Analogs of deoxythymidine-5'-triphosphate (dTTP) were synthesized from dUTP (SigmaAldrich, Missouri) and characterized as described below. Primer: 5'-GTC CCT GTT CGG GCG CCA and template: 5' -TGT GTG TGC GTT CTC GTT CTA TGG CGC CCG AAC AGG GAC were custom-made by Integrated DNA Technologies, Inc (Coralville, IA). T7 RNA polymerase was purchased from New England Biolabs (Ipswich, MA). HIV-1 RT was from Worthington Biochemical Corporation (Lakewood, NJ). Electrospray ionisation (ES) mass spectrometry (MS) was conducted by Florida University facilities.
Synthesis of dTTP analogs.
5-(Aminomethyl)-2'-deoxyuridine-5'-triphosphate, Triethylammonium salt (aadTTP) was synthesized by using the procedure by Langer et al.
Synthesis of 6-azidohexanoic acid: 1.94 g (10 mmol) of 6-bromohexanoic acid (ACROS) and 1.3 g (20 mmol) of sodium azide (ACROS) were added to 10 mL of previously dried N,Ndimethylformamide (ACROS). The solution was stirred at room temperature for 36 hr. The product was extracted with 15 mL of dichloromethane, and the organic layer was washed three times with 20% aqueous lithium chloride and dried over anhydrous magnesium sulfate overnight at 4 o C. The solvent was then evaporated under vacuum, and the product, a colorless oil, was characterized by 1 H-NMR (400 MHz, CDCl 3 , ppm): 1.38 (m, 2H); 1.59 (m, 4H); 2.32 (t, 2H); 3.23 (t, 2H); 10.47 (s, 1 H) and 13 C-NMR (ppm): 24.48; 26.47; 28.85; 34.18; 51.9; 180 .00 (Yield: 71%, 1.109 g).
Synthesis of 5-allyl(6-azidohexanamide) dTTP (6Az-dTTP): 6-azidohexanoic acid (7.28 µL 46.6 µmol) was added to a 1 mL solution containing N-hydroxysuccinimide (ACROS) (5.9 mg, 51.3 µmol) and dicyclohexylcarbodiimide (ACROS) (11.5 mg, 56 µmol) in 1 mL N,Ndimethylformamide (ACROS). The solution was rocked for 30 minutes, and the solution was separated from dicyclohexylurea by centrifugation at 10000 rpm for 5 minutes at 4 o C. 3. Substrate Properties of dTTP analogs and PAGE analysis. The substrate properties were tested by incubating 30 µL sample containing 5 µM dTTP or dTTP containing fluorescein labeled primer in complex with template (1 µM), HIV-RT (50 nM) in reaction buffer (50 mM Tris-HCl pH = 8, 100 mM KCl, 8 mM MgCl 2 , BSA 100 mg/mL, and DTT 2 mM). After incubation 30 min at 37 o C, 1.5 µL dVTPs (dATP, dCTP, and dGTP) to the final concentration of 5 mM were added to 15 µL aliquot of the previously incubated mixture for substrate properties, while 1.5 µL of the second analog was added to the 30 µL inhibition property samples. The reaction mixtures were incubated for additional 30 min (dVTP-containing) or 20 min (second analog-containing) at 37 o C. The inhibition samples were then aliquoted into two samples containing 15.75 µL, and 1.5 mL of dNTPs were added to one of the aliquots and incubated for 30 min at 37 o C. All reactions were quenched by the addition of loading buffer (70% formamide, 0.05% bromophenol blue, 29.95% glycerol, and 20 mM EDTA) upon their respective final incubation. The reaction mixtures were then boiled for 5 minutes in a water bath and added to a 15% dPAGE gel. The gel was run at 400 V for 50 min at 55 o C. To demonstrate that inhibition was due to the incorporation of the analog and the subsequent click-reaction, a dPAGE gel was run by using a control sample containing dTTP where the dNTPs were added at the same time when dNTPs were added to the inhibition samples, after 50 min of incubation.
Filter binding assay (FBA) Analysis of Elongation, Inhibition, and Specificity.
A filter binding assay (FBA) was employed to quantify primer elongation by dNTPs after the addition of dTTP, analogs, and TCCI combinations. For the FBA, a master mix containing fluorescein-labeled primer/template (1 µM), HIV-RT (50 nM), BSA 100 µg/mL, DTT (2 mM), and HIV-RT buffer was aliquoted into six 15 mL portions: Sample 1 (negative control), samples 2, 3, and 4 (dTTP, 6Az-dTTP, and DBCO-dTTP respectively), and samples 5 and 6 (6Az-dTTP and DBCOdTTP). The samples were incubated for 45 min at 37 o C. After the first step elongation, 15 mL of FBA master mix (1 mM dTTP, 1 mM dATP, 1 mM dCTP, and 10 mM 3 H-dGTP) was added to samples 1 through 4 and incubated for an additional 45 min, while DBCO-dTTP was added to sample 5 and 6Az-dTTP was added to sample 6 and incubated for 30 min. After the 30 min elapsed, FBA master mix was added to samples 5 and 6, and further incubated for 45 min, while samples 1 through 4 were quenched by the addition of 30 mL of 0.5 M EDTA and placed on ice. All samples were then added to anion exchange filter papers (Whatman DE-80) and allowed to air dry. The dried filter papers were then washed twice with two 50 mL portions of 0.5 M sodium phosphate buffer at pH 6.8, followed by one ethanol wash. After washing, the filter papers were dried followed by transferring in 25 mL scintillation vials containing 7 mL of BD scintillation cocktail. Radiation was then measured by a scintillation counter (Beckmann 5900), and the reported values in counts per minute (CPM) were normalized to the value given by sample 2, which contains natural substrates. The experiment was run in triplicate to ensure statistical significance and normalized to the elongation of natural dNTPs. 
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Electrospray ionization (ES) mass spectrometry (MS) Figure S5 . Electrospray ionization mass spectrum of P/T elongated by HIV-1 RT in the presence 6Az-dTTP, following by addition of DBCO-dTTP (Lane 8 in Figure 1 ). The two click products m/z 7150 and 7249 were monophosphate and diphosphate derivative, the products of triphosphate group degradation during sample manipulation. Figure S6 . Electrospray ionization mass spectrum of P/T elongated by HIV-1 RT in the presence DBCO-dTTP, following by addition of 6Az-dTTP (Lane 10 in Figure 1 ). The main band 6594.1 Da does not correspond to the predicted 6694 Da predicted for DBCO-dTMP elongated primer or the 7150 and 7249 click products.
